LncRNA HCP5 promotes the progression of gastric cancer through the miR-526b/PBX3 axis
HCP5 acts as an oncogenic lncRNA in GC by promoting cell viability, migration, and proliferation via the miR-526b/PBX3 axis. Targeting the HCP5/miR-526b/PBX3 axis may represent a promising therapeutic strategy for GC.
Authors
- Guang-Chuan Mu
Institutions
- First Affiliated Hospital of GuangXi Medical University (CN)
Publication Details
- Journal
- American Journal of Translational Research
- Published
- 2025-01-01
- DOI
- https://doi.org/10.62347/ioyf4383
- Primary Topic
- Cancer-related molecular mechanisms research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Guangxi Medical University